ABATACEPT: A NEW CHOICE FOR CHILDREN WITH POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS
Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disorder in children. Children with polyarticular curse JIA, who do not respond to non-steroidal anti-inflammatory drugs and steroid injections, are treated with disease modyfing anti-rheumatic drugs with the first choice being...
Main Author: | N. Ruperto |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2010-03-01
|
Series: | Voprosy Sovremennoj Pediatrii |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/602 |
Similar Items
-
ABATACEPT: A NEW CHOICE FOR CHILDREN WITH POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS
by: N. Ruperto
Published: (2010-01-01) -
EFFICACY OF ABATACEPT IN A PATIENT WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS REFRACTORY TO TNF-α
by: Yu. M. Spivakovskii, et al.
Published: (2015-04-01) -
EFFICACY AND SAFETY OF COMBINATION TREATMENT WITH ABATACEPT AND METHOTREXATE AND MONOTHERAPY WITH METHOTREXATE IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
by: V. A. Kel'tsev, et al.
Published: (2012-11-01) -
Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study
by: Ryoki Hara, et al.
Published: (2019-04-01) -
Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2–5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept
by: Hermine I. Brunner, et al.
Published: (2020-02-01)